StudyGraphics #VisualAbstract: Avelumab does not improve outcomes in patients receiving chemoradiotherapy for squamous cell carcinomas of the head and neck May 6, 2021 | Teddy Guo Facebook Twitter Pinterest WhatsApp Linkedin ReddIt Email Print Click to read the study in The Lancet Oncology. RELATED ARTICLESMORE FROM AUTHOR #VisualAbstract Patients with follicular lymphoma experience a plateau in therapy initiation rates during their first decade of observation after diagnosis Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response #VisualAbstract Cases of post-COVID-19 diffuse hair shedding may have a delayed presentation and be shorter in duration than typical acute telogen effluvium
